PF-1355, a Mechanism-Based Myeloperoxidase Inhibitor, Prevents Immune Complex Vasculitis and Anti–Glomerular Basement Membrane Glomerulonephritis-Reference-Cited by-同舟云学术

PF-1355, a Mechanism-Based Myeloperoxidase Inhibitor, Prevents Immune Complex Vasculitis and Anti–Glomerular Basement Membrane Glomerulonephritis

Published:2015-02-19 Issue:2 Volume:353 Page:288-298
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Zheng Wei,Warner Roscoe,Ruggeri Roger,Su Chunyan,Cortes Christian,Skoura Athanasia,Ward Jessica,Ahn Kay,Kalgutkar Amit,Sun Dexue,Maurer Tristan S.,Bonin Paul D.,Okerberg Carlin,Bobrowski Walter,Kawabe Thomas,Zhang Yanwei,Coskran Timothy,Bell Sammy,Kapoor Bhupesh,Johnson Kent,Buckbinder Leonard

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference48 articles.

1. Diagnostic and pathogenetic role of antineutrophil cytoplasmic autoantibodies

2. Molecular mechanisms regulating NETosis in infection and disease

3. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury

4. Late Intervention with a Myeloperoxidase Inhibitor Stops Progression of Experimental Chronic Obstructive Pulmonary Disease

5. Advances in human antiglomerular basement membrane disease

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local Drug Delivery Systems as Novel Approach for Controlling NETosis in Periodontitis;Pharmaceutics;2024-09-06

2. In-situ evaluation the fluctuation of hypochlorous acid in acute liver injury mice models with a mitochondria-targeted NIR ratiometric fluorescent probe;Talanta;2024-09

3. Myeloperoxidase inhibition protects bone marrow mononuclear cells from DNA damage induced by the TOP2 poison anti‐cancer drug etoposide;FEBS Open Bio;2024-03-26

4. The Concept of Thromboinflammation;Hämostaseologie;2024-02

5. Drug upgrade: A complete methodology from old drug to new chemical entities using Nematic Protein Organization Technique;Drug Development Research;2024-01-16